The University of Chicago Header Logo

Connection

Rolf Barth to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications Rolf Barth has written about Antineoplastic Agents, Immunological.
Rolf Barth
Connection Strength
0.138
Antineoplastic Agents, Immunological
  1. Alemtuzumab induction and belatacept maintenance in marginal pathology renal allografts. Clin Transplant. 2019 06; 33(6):e13531.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.